KALV Q1 2026 Earnings Narrower Loss Beats Expectations Clinical Pipeline Progress Underway Teva Q1 2026 Earnings Strong EPS Beat on Cost Discipline Shares Edge Higher CON Q1 2026 Earnings Solid EPS Beat Masks Cautious Market Sentiment RCUS Q1 2026 Earnings EPS Misses Estimates Despite Stock Uptick PAYC Q1 2026 Earnings EPS Beat Drives Cautious Sentiment PAPL Q3 2025 Earnings NarrowerthanExpected Loss Boosts Sentiment Despite Negative Market Reaction